FierceBiotech

Revised Clinical Trial Principles Reinforce PhRMA's Commitment To Transparency and Strengthen Authorship Standards

Washington, D.C. (April 20, 2009) - Reflecting the continued commitment of America's pharmaceutical research and biotechnology companies to encourage practices that best serve the needs of patients ...
Nanowerk

Synthetic membraneless organelles for biotechnology applications reviewed

A new review outlines design principles and applications of synthetic membraneless organelles built through liquid-liquid phase separation for use in biotechnology.
FierceBiotech

EFPIA and PhRMA Release Joint Principles for Responsible Clinical Trial Data Sharing to Benefit Patients

WASHINGTON & BRUSSELS--(BUSINESS WIRE)--The European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA) today ...
FiercePharma

Biotech CEOs pen standards for coronavirus trials, data disclosures amid FDA reputation crisis

Amid doubts about the FDA’s decision-making process during the pandemic, biotech CEOs on the front lines of research are laying out their approach and asking “all parties” involved in the process to ...
Eagle-Tribune

Aseptic Processing of Pharmaceutical and Biotech Products Training Course: Fundamental Principles, Advanced Techniques, and Regulatory Insights (Dec 11th - Dec 12th, 2025 ...

The "Aseptic Processing of Pharmaceutical and Biotech Products Course (Dec 11th - Dec 12th, 2025)" training has been added to ResearchAndMarkets.com's offering.